← Back to Clinical Trials
Recruiting NCT04128670

NCT04128670 Effects of Kinesio Tape on Delayed Onset Muscle Soreness

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04128670
Status Recruiting
Phase
Sponsor Indiana University
Condition Delayed Onset Muscle Soreness
Study Type INTERVENTIONAL
Enrollment 36 participants
Start Date 2020-01-30
Primary Completion 2026-05-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 30 Years
Study Type INTERVENTIONAL
Interventions
Kinesiotape

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 36 participants in total. It began in 2020-01-30 with a primary completion date of 2026-05-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to determine the effect of Kinesio tape on delayed onset muscle soreness of the biceps muscle of your arm following strenuous exercise of the bicep muscle.

Eligibility Criteria

Inclusion Criteria: * 18 to 30 years old Exclusion Criteria: * Participating in any strengthening exercises or activities of the upper extremities for the past month. * Regularly (\~2x per month) participating in strengthening exercises or activities that include lengthening actions of the upper extremity for the past 6 months. * An answer of yes to any of the seven questions on the first page of the 2019 Physical Activity Readiness Questionnaire \[PAR-Q: 16\] indicating that the subject is not physically ready for exercise without a medical exam. These exclusions include the following: * If participant's doctor has ever said that he/she has a heart condition or high blood pressure * Pain in chest at rest, during daily activities of living, or when doing physical activity * If participant has ever lost balance because of dizziness or has lost consciousness in the past 12 months * If the participant currently has (or have had within the past 12 months) a bone, joint, or soft tissue (muscle, ligament, or tendon) problem that could be made worse by becoming more physically activity * If participant is currently taking prescribed medications for a chronic medical condition * If the participant's doctor has ever told them that they should only do medically supervised physical activity. * Currently taking nutritional supplements or anti-inflammatory medication on a daily basis * Any injury or surgery to the neck or upper extremity in the past 6 months * Open or scabbed wounds in the arm area to be taped * Known allergies to the tape or medical adhesive bandages * If skin irritation develops to the tape Session exclusion criteria: ● Taking over-the-counter pain medications on days of testing, prior to testing sessions, including acetaminophen (Tylenol) and nonsteroidal inflammatory drugs (NSAIDs), including ibuprofen (Motrin, Advil) or naproxen (Aleve, Naprosyn).

Contact & Investigator

Central Contact

Kelly M Naugle, PhD

✉ kmnaugle@iupui.edu

📞 3172740601

Frequently Asked Questions

Who can join the NCT04128670 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Delayed Onset Muscle Soreness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04128670 currently recruiting?

Yes, NCT04128670 is actively recruiting participants. Contact the research team at kmnaugle@iupui.edu for enrollment information.

Where is the NCT04128670 trial being conducted?

This trial is being conducted at Indianapolis, United States.

Who is sponsoring the NCT04128670 clinical trial?

NCT04128670 is sponsored by Indiana University. The trial plans to enroll 36 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology